Late-onset, giant juvenile xanthogranuloma.

Autor: Sripati, Tirumala¹ (AUTHOR), Lisa, Mona² (AUTHOR) monaloud@gmail.com, Kumar, Nikhil² (AUTHOR), Roy, Asitava Deb² (AUTHOR), Kumar, Amit¹ (AUTHOR)

Publikováno v: Journal of Laboratory Physicians. Oct-Dec2024, Vol. 16 Issue 4, p1-4. 4p.

Clofarabine monotherapy in aggressive, relapsed and refractory Langerhans cell histiocytosis.

Autor: Parekh D; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas, USA.; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, Texas, USA., Lin H; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas, USA.; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, Texas, USA., Batajoo A; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas, USA.; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, Texas, USA., Peckham-Gregory E; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas, USA.; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, Texas, USA., Karri V; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas, USA.; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, Texas, USA., Stanton W; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas, USA.; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, Texas, USA., Scull B; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas, USA.; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, Texas, USA., Fleishmann R; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas, USA.; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, Texas, USA., El-Mallawany N; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas, USA.; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, Texas, USA., Eckstein OS; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas, USA.; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, Texas, USA., Prudowsky ZD; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas, USA.; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, Texas, USA., Gulati N; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas, USA.; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, Texas, USA.; Department of Pediatrics, Weill Cornell Medical College, New York, New York, USA., Agrusa JE; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas, USA.; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, Texas, USA.; Division of Pediatric Hematology/Oncology, C.S. Mott Children's Hospital, University of Michigan Medical School, Ann Arbor, Michigan, USA., Ahmed AZ; Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA., Chu R; Division of Hematology/Oncology/BMT, Central Michigan University College of Medicine, Children's Hospital of Michigan, Detroit, Michigan, USA., Dietz MS; Division of Pediatric Hematology and Oncology, University of Utah, Primary Children's Hospital, Salt Lake City, Utah, USA., Goldman SC; Pediatric Hematology/Oncology, Medical City Children's Hospital, Dallas, Texas, USA., Hogarty MD; Division of Oncology, Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Imran H; Department of Pediatrics, University of South Alabama, Mobile, Alberta, USA., Intzes S; Department of Pediatric Hematology/Oncology, Sacred Heart Children's Hospital, Spokane, Washington, USA., Kim JM; Department of Pediatrics, Division of Hematology/Oncology, University of California San Diego School of Medicine, Rady Children's Hospital, San Diego, California, USA., Kopp LM; Department of Pediatrics, University of Arizona, Mel and Enid Zuckerman College of Public Health, Tucson, Arizona, USA., Levy CF; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Cohen Children's Medical Center, Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA., Neff P; Children's Blood and Cancer Center, The University of Texas at Austin, Dell Children's Medical Center of Central Texas, Austin, Texas, USA., Pillai PM; Jack Martin Division of Pediatric Hematology-Oncology, Jack and Lucy Clark Department of Pediatrics, Mount Sinai Kravis Children's Hospital, New York, New York, USA., Sisk BA; Division of Pediatric Hematology and Oncology, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA., Schiff DE; Department of Pediatrics, Division of Hematology/Oncology, University of California San Diego School of Medicine, Rady Children's Hospital, San Diego, California, USA., Trobaugh-Lotrario AD; Department of Pediatric Hematology/Oncology, Sacred Heart Children's Hospital, Spokane, Washington, USA., Walkovich K; Division of Pediatric Hematology/Oncology, C.S. Mott Children's Hospital, University of Michigan Medical School, Ann Arbor, Michigan, USA., McClain KL; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas, USA.; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, Texas, USA., Allen CE; Texas Children's Cancer Center, Texas Children's Hospital, Houston, Texas, USA.; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, Texas, USA.

Publikováno v: British journal of haematology [Br J Haematol] 2024 May; Vol. 204 (5), pp. 1888-1893. Date of Electronic Publication: 2024 Mar 19.

Rare Pediatric Non-Hodgkin Lymphomas: A Report From Children's Oncology Group Study ANHL 04B1.

Autor: O'Suoji C; Division of Pediatric Hematology/Oncology, West Virginia University, Charleston, West Virginia., Welch JJ; Division of Pediatric Hematology/Oncology, Hasbro Children's Hospital, Alpert Medical School Brown University, Providence, Rhode Island., Perkins SL; Department of Pathology, University of Utah Health Sciences, Salt Lake City, Utah., Smith LM; Department of Biostatistics, University of Nebraska Medical Center, Omaha, Nebraska., Weitzman S; Division of Pediatric Hematology/Oncology, Hospital for Sick Children, Toronto, Ontario, Canada., Simko SJ; Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas., Galardy PJ; Division of Pediatric Hematology/Oncology, Mayo Clinic, Rochester, Minnesota., Bollard CM; Children's National Health System, The George Washington University, Washington, District of Columbia., Gross TG; National Cancer Institute, Rockville, Maryland., Termuhlen AM; Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California.

Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2016 May; Vol. 63 (5), pp. 794-800. Date of Electronic Publication: 2016 Jan 05.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.